Fatty acids in plasma, white and red blood cells, and tissues after oral orintravenous administration of fish oil in rats

Clinical Nutrition

Volumn 32, Issue 6, 2013, Pages 993-998

  Barros, Karina V ^a,b   Carvalho, Patricia O ^c   Cassulino, Ana P ^a   Andrade, Iracema ^a   West, Annette L ^b   Miles, Elizabeth A ^b   Calder, Philip C ^b   Silveira, Vera L F ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^c UNIVERSIDADE SÃO FRANCISCO   (Brazil)

Author keywords

Lipid emulsion; N 3 PUFA; N 6 PUFA; Polyunsaturated fatty acids

Indexed keywords

DOCOSAHEXAENOIC ACID; FISH OIL; ICOSAPENTAENOIC ACID; MONOUNSATURATED FATTY ACID; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; PHOSPHATIDYLCHOLINE; SATURATED FATTY ACID; SOYBEAN OIL; TRANS FATTY ACID;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CENTRAL VENOUS CATHETER; CONTROLLED STUDY; EMULSION; ERYTHROCYTE; FATTY ACID BLOOD LEVEL; FEEDING; GAS CHROMATOGRAPHY; HEART; LEUKOCYTE; LIPID COMPOSITION; LIVER; LUNG; MALE; NONHUMAN; RAT;

ARA; ARACHIDONIC FATTY ACID; DHA; DOCOSAHEXAENOIC ACID; DOCOSAPENTAENOIC ACID; DPA; EICOSAPENTAENOIC ACID; EPA; FA; FATTY ACID; FISH OIL; FISH OIL BASED LIPID EMULSION; FLE; FO; LIPID EMULSION; N-3 PUFA; N-6 PUFA; POLYUNSATURATED FATTY ACID; POLYUNSATURATED FATTY ACIDS; PUFA; RBC; RED BLOOD CELL; SLE; SO; SOYBEAN OIL; SOYBEAN OIL BASED LIPID EMULSION; WBC; WHITE BLOOD CELL;

ADMINISTRATION, INTRAVENOUS; ADMINISTRATION, ORAL; ANIMALS; DOCOSAHEXAENOIC ACIDS; EICOSAPENTAENOIC ACID; ERYTHROCYTES; FATTY ACIDS, UNSATURATED; FISH OILS; LEUKOCYTES; MALE; PHOSPHATIDYLCHOLINES; RATS; RATS, WISTAR; SOYBEAN OIL;

EID: 84887626906     PISSN: 02615614     EISSN: 15321983     Source Type: Journal    
DOI: 10.1016/j.clnu.2013.02.010     Document Type: Article

References (35)

1. Calder P.C., Albers R., Antoine J.M., Blum S., Bourdet-Sicard R., Ferns G.A., et al. Inflammatory disease processes and interactions with nutrition. Br J Nutr 2009, 10:S1-S45.
2. Calder P.C., Ahluwalia N., Brouns F., Buetler T., Clement K., Cunningham K., et al. Dietary factors and low-grade inflammation in relation to overweight and obesity. Br J Nutr 2011, 106:S5-S78.
3. Bone R.C., Balk R.A., Cerra F.B., Dellinger R.P., Fein A.M., Knaus W.A., et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 1997, 1644-1655.
4. Calder P.C. Long-chain fatty acids and inflammation. Proc Nutr Soc 2012, 71:284-289.
5. Calder P.C. N-3 polyunsaturated fatty acids, inflammation, and inflammatory diseases. Am J Clin Nutr 2006, 83:1505S-1519S.
6. Calder P.C. Fatty acids and inflammation: the cutting edge between food and pharma. Eur J Pharmacol 2011, 668:S50-S58.
7. Calder P.C. Omega-3 polyunsaturated fatty acids and inflammatory processes: nutrition or pharmacology?. Br J Clin Pharmacol 2013, 75:645-662.
8. Calder P.C. The relationship between the fatty acid composition of immune cells and their function. Prostaglandins Leukot Essent Fatty Acids 2008, 79:101-108.
9. Calder P.C. Mechanisms of action of (n-3) fatty acids. JNutr 2012, 142:592S-599S.
10. Yaqoob P., Pala H.S., Cortina-Borja M., Newsholme E.A., Calder P.C. Encapsulated fish oil enriched in α-tocopherol alters plasma phospholipid and mononuclear cell fatty acid compositions but not mononuclear cell functions. Eur J Clin Invest 2000, 30:260-274.
11. Faber J., Berkhout M., Vos A.P., Sijben J.W., Calder P.C., Garssen J., et al. Supplementation with a fish oil-enriched, high-protein medical food leads to rapid incorporation of EPA into white blood cells and modulates immune responses within one week in healthy men and women. JNutr 2011, 141:964-970.
12. Browning L.M., Walker C.G., Mander A.P., West A.L., Madden J., Gambell J.M., et al. Incorporation of eicosapentaenoic and docosahexaenoic acids into lipid pools when given as supplements providing doses equivalent to typical intakes of oily fish. Am J Clin Nutr 2012, 96:748-758.
13. Calder P.C. PUFA, inflammatory processes and rheumatoid arthritis. Proc Nutr Soc 2008, 67:409-418.
14. Miles E.A., Calder P.C. Influence of marine n-3 polyunsaturated fatty acids on immune function and a systematic review of their effects on clinical outcomes in rheumatoid arthritis. Br J Nutr 2012, 107:S171-S184.
15. Calder P.C. Polyunsaturated fatty acids, inflammatory processes and inflammatory bowel diseases. Mol Nutr Food Res 2008, 52:885-897.
16. Thies F., Garry J.M.C., Yaqoob P., Rerkasem K., Williams J., Shearman C.P., et al. Association of n-3 polyunsaturated fatty acids with stability of atherosclerotic plaques: a randomised controlled trial. Lancet 2003, 361:477-485.
17. Cawood A.L., Ding R., Napper F.L., Young R.H., Williams J.A., Ward M.J., et al. Eicosapentaenoic acid (EPA) from highly concentrated n-3 fatty acid ethyl esters is incorporated into advance atherosclerotic plaques and higher plaque EPA is associated with decreased plaque inflammation and increased stability. Atherosclerosis 2010, 212:252-259.
18. Pittet Y.K., Berger M.M., Pluess T., Voiirol P., Revelly J.P., Tappy L., et al. Blunting the response to endotoxin in healthy subjects: effects of various dose of intravenous fish oil. Intensive Care Med 2012, 36:289-295.
19. Versleijen M.W., Roelofs H.M., Rombouts C., Hermans P.W., Noakes P.S., Calder P.C., et al. Short-term infusion of a fish oil-based lipid emulsion modulates fatty acid status, but not immune function or (anti) oxidant balance: a randomized cross-over study. Eur J Clin Invest 2012, 42:290-302.
20. Pluess T.T., Hayoz D., Berger M.M., Tappy L., Revelly J.P., Michaeli B., et al. Intravenous fish oil blunts the physiological response to endotoxin in healthy subjects. Intensive Care Med 2007, 33:789-797.
21. Simoens C.M., Deckelbaum R.J., Massaut J.J., Carpentier Y.A. Inclusion of 10% fish oil in mixed medium-chain triacylglycerol longchain triacylglycerol emulsions increases plasma triacylglycerol clearance and induces rapid eicosapentaenoic acid (20:5n-3) incorporation into blood cell phospholipids. Am J Clin Nutr 2008, 88:282-288.
22. Barbosa V.M., Miles E.A., Calhau C., Lafuente E., Calder P.C. Effects of a fish oil containing lipid emulsion on plasma phospholipid fatty acids, inflammatory markers, and clinical trial. Crit Care 2010, 14:R5.
23. Leeb B.F., Sautner J., Andel I., Rintelen B. Intravenous application of Ômega-3 fatty acids in patients with active rheumatoid arthritis. The ORA-1 trial. An open pilot study. Lipids 2006, 41:29-34.
24. Mayser P., Mrowietz U., Arenberger P., Bartak P., Buchvald J., Christophers E., et al. Omega-3 fatty acid-based lipid infusion in patients with chronic plaque psoriasis: results of a double-blind, randomized, placebo-controlled, multicenter trial. JAm Acad Dermatol 1998, 38:539-547.
25. Schrepf R., Limmert T., Claus Weber P., Theisen K., Sellmayer A. Immediate effects of n-3 fatty acid infusion on the induction of sustained ventricular tachycardia. Lancet 2004, 363:1441-1442.
26. Wei C., Hua J., Bin C., Klassen K. Impact of lipid emulsion containing fish oil on outcomes of surgical patients: systematic review of randomized controlled trials from Europe and Asia. Nutrition 2010, 26:474-481.
27. Mayer K., Gokorsch S., Fegbeutel C., Hattar K., Rosseau S., Walmrath D., et al. Parenteral nutrition with fish oil modulates cytokine response in patients with sepsis. Am J Respir Crit Care Med 2003, 167:1321-1328.
28. Heller A.R., Rössler S., Litz R.J., Stehr S.N., Heller S.C., Koch R., et al. Omega-3 fatty acids improve the diagnosis-related clinical outcome. Crit Care Med 2006, 34:972-979.
29. Wang X., Li W., Li N., Li J. Omega-3 fatty acids-supplemented parenteral nutrition decreases hyperinflammatory response and attenuates systemic disease sequelae in severe acute pancreatitis: a randomized and controlled study. JParenter Eternal Nutr 2008, 32:236-241.
30. Katan M.B., Deslypere J.P., Van Birgelen A.P., Penders M., Zegwaard M. Kinetics of the incorporation of dietary fatty acids into serum cholesteryl esters, erythrocytes membranes, and adipose tissue: an 18-month controlled study. JLipid Res 1997, 38:2012-2022.
31. Harris W.S., Sands S.A., Windsor S.L., Ali H.A., Stevens T.L., Magalski A., et al. Omega-3 fatty acids in cardiac biopsies from heart transplantation patients: correlation with erythrocytes and response to supplementation. Circulation 2004, 110:1645-1649.
32. Saravanan P., Bridgewater B., West A.L., O'Neill S.C., Calder P.C., Davidson N.C. Omega-3 fatty acid supplementation does not reduce risk of atrial fibrillation after coronary artery bypass surgery: a randomized, double-blind, placebo-controlled clinical trial. Circ Arrhythm Electrophysiol 2010, 3:46-53.
33. Calder P.C., Yaqoob P. Understanding omega-3 polyunsaturated fatty acids. Postgrad Med 2009, 121:148-157.
34. Ikeda I., Sasaki E., Yasunami H., Nomiyama S., Nakayama M., Sugano M., et al. Digestion and lymphatic transport of eicosapentaenoic and docosahexaenoic acids given in the form of triacylglycerol, free acid and ethyl ester in rats. Biochim Biophys Acta 1995, 1259:297-304.
35. Nordoy A., Barstad L., Connor W.E., Hatcher L. Absorption of the n-3 eicosapentaenoic and docosahexaenoic acids as ethyl esters and triglycerides by human. Am J Clin Nutr 1991, 53:1185-1190.